Arzeda

Arzeda is a private, revenue-generating company founded in 2008 that sits at the intersection of synthetic biology and AI. Its core competency is the computational design of novel enzymes and proteins for industrial applications, moving beyond natural evolution to create optimized biocatalysts. The company has demonstrated commercial traction with products like its stevia sweetener, ProSweet Reb M™, and secures significant non-dilutive funding through partnerships with entities like DARPA and the NSF. Arzeda's business model combines platform licensing, collaborative R&D, and proprietary product development to address sustainability challenges in multiple sectors.

Intelligent Protein Design Technology™ combining physics-based protein design and AI/ML to create novel enzymes and proteins.

Arzeda competes in the computational protein design space with other synthetic biology platforms like Ginkgo Bioworks (enzyme services) and Codexis (enzyme engineering), as well as a growing number of AI-native biotech startups. Its differentiation lies in the deep integration of physics-based design with AI and a focus on industrial, non-therapeutic applications.